Keywords
Listeria monocytogene, listeriosis, Foodborne disease
Listeria monocytogene, listeriosis, Foodborne disease
Listeria monocytogenes (Lm) is ubiquitous in the environment and potentially an enteropathogen.Lmis the causative agent of the foodborne disease listeriosis and is thus a major concern in the food industry. Lm switches between saprophytism and virulence depending on its environmental context. Lm can replicate intracellularly in a variety of cell types, can traverse several host barriers, and has long been used as a model of infection. The capacity of Lm to infect multiple tissues has underlined the cell-type-dependent role of different bacterial and host proteins.
Lm can infect a wide variety of cell types during its dissemination in the host, invading both phagocytic and non-phagocytic cells in a variety of tissues1. Following internalization into the host cell, the bacterium escapes its membrane-bound vacuole and replicates within the cytosol. The bacterium then subverts the host cytoskeleton, inducing characteristic actin “comet tails” to drive both intracellular and intercellular movements. The most important virulence factor (in addition to actin assembly-inducing protein [ActA]2 responsible for the actin-based motility, and the two invasion proteins internalin A [InlA] and internalin B [InlB]), is certainly listeriolysin O (LLO)3. This pore-forming toxin appears to be a multifaceted factor involved in several steps of infection, before bacterial entry into cells, at the level of the escape from the vacuole, and in the cytosol.
Here, we review recent advances in the understanding of Lm infection with a particular focus on the importance of taking into account the subcellular and physiological environmental context. We highlight some recently discovered cues used by Lm to sense entry into the host as a signal to regulate virulence. Furthermore, we discuss new aspects of Lm subversion of the actin cytoskeleton. We also provide recent updates on how Lm crosses physiological barriers, notably the small intestine and placenta. Recent work has also uncovered the interaction between Lm and the host gut microbiota, highlighting the importance of considering not only standard laboratory strains of Lm but also other strains as a source of discovery of novel virulence factors.
Upon entry into the host cell, Lm is known to modify its transcriptional program4–7. The transcription factor positive regulatory factor A (PrfA) is a master transcriptional activator of genes necessary for Lm pathogenesis, including prfA itself8,9. The expression of prfA is regulated by a variety of cues, allowing Lm to adapt to different environments. PrfA translation is known to be dependent on temperature, with higher translation levels at 37°C compared to 30°C10. Recently, it was found that the scarcity of branched-chain amino acids, as would be encountered by Lm during infection, leads to upregulation of prfA transcription11,12. Furthermore, glutathione, abundant within the host cytosol, has been uncovered as an allosteric activator of PrfA protein activity13,14. In addition to activating PrfA, glutathione was discovered to covalently attach to a conserved cysteine on LLO15. This S-glutathionylation abolishes LLO hemolytic activity, but the precise mechanism by which this reversible post-translational modification affects infection is unknown.
L-glutamine, abundant within host blood plasma and host cell cytosol, has recently been reported as another major cytosolic cue for the upregulation of virulence genes in Lm16. It is currently unknown whether L-glutamine, similarly to glutathione, affects PrfA activity at the post-translational level.
To further investigate the cues sensed by Lm for the regulation of virulence, a screen was performed to identify Lm genes required for expression of the surface protein ActA17. Interestingly, most of the genes important for ActA expression are implicated in bacterial redox homeostasis. Since the host cell can induce oxidative stress as a means of antibacterial activity, redox changes may serve as another cue for the regulation of virulence genes in Lm.
The discovery of novel environmental cues sensed by Lm will continue to be important for the study of the infectious process. Indeed, earlier studies have shown an intracellular upregulation of some virulence factors, e.g. InlK or LntA, but the exact cues were not elucidated18,19. Interestingly, other virulence factors such as InlJ or LLS are not expressed in cultured cells but are upregulated in vivo either in the liver and blood20 or within the intestine21, again upon undefined environmental cues. Thus, further work is required to determine what currently uncharacterized signals may be sensed by Lm for the upregulation and activation of virulence genes that are poorly expressed in vitro.
It has long been known that actin polymerization drives Lm host cell entry22 as well as intracellular and intercellular motility23. Once Lm reaches the host cytosol, ActA is transcriptionally upregulated and localized to the bacterial cell surface, where it recruits and activates the host actin regulator the actin-related protein 2/3 (Arp2/3) complex24. The resulting actin cloud surrounding the bacteria enables it to evade detection by the host autophagy machinery25–27. ActA polarization at one of the bacterial cell poles results in a polarized polymerization of actin. The resulting actin “comet tails” propel the bacteria within the host cell cytosol and facilitate cell-to-cell spread. Although this process is well characterized, recent results have uncovered novel insights into the composition of the host Arp2/3 complex, how the actin cytoskeleton is involved in intracellular and intercellular motility, and how these processes are dependent on the stage of infection and subcellular context.
Exploiting the Arp2/3 complex during infection. The Arp2/3 complex is composed of seven subunits: the Arp2 and Arp3 proteins and five Arp complex proteins (ARPC1–5)28–32. When activated by nucleation-promoting factors, it binds to a pre-existing actin filament and catalyzes the formation of a de novo Y-branched actin filament. Interestingly, Lm ActA mimics host nucleation-promoting factors to recruit and activate Arp2/3 near the bacterial surface32.
We recently discovered differential requirements for subunits of the Arp2/3 complex for distinct aspects of Lm infection that require actin, i.e. entry and actin-based motility33. Strikingly, ARPC1B, but not ARPC1A, appears to be critical for efficient Lm cell invasion. In contrast, ARPC1A, but not ARPC1B, is required for actin comet tail formation. Together, these results suggest that different isoforms of ARPC1 are exploited by Lm differently. Both ARPC4 and ARPC5 appear to be dispensable for cell invasion. In contrast, ARPC5 is not critical for actin tail formation. Thus, rather than existing as a single canonical complex, different Arp2/3 complexes may be formed by different subunits, and this modularity can be exploited by Lm for distinct steps of infection33. The mechanism by which Lm can activate different Arp2/3 complexes and the effect of differential Arp2/3 activation on the actin cytoskeleton are still unknown.
It is currently unclear whether different Arp2/3 complexes exist and play a role in vivo. Nevertheless, the existence of different Arp2/3 complexes has also been recently reported in the case of focal adhesions34 and the actin-driven intracellular propulsion of vaccinia virus35. The recent discovery of sick but living human children with frameshift mutations in ARPC1B, the predominant ARPC1 isoform expressed in blood cells36, suggests critical but distinct roles for different components of the Arp2/3 complex in vivo.
Moving inside cells: mechanisms of Lm intracellular propulsion. Actin polymerization is known to propel intracellular Lm, but the precise mechanism of force generation has remained unclear. There are two prevailing models for actin polymerization-dependent intracellular propulsion of Lm. In the “Brownian ratchet” model, growing tangential actin filaments protrude and provide the propulsive force37. The alternate “macroscale elastic propulsion” model implicates large-scale deformation of the actin meshwork as propelling the bacterium forward37. Whether Lm intracellular propulsion is driven by individual actin filament elongation or by elasticity of the actin network was unclear.
Recent cryo-electron tomography of Lm-associated actin comet tails both within the cell38 and within cell-free extracts39 has shed some light on this process. The network of actin comet tails is composed of both branched and, surprisingly, some bundled filaments39. The novel discoveries of additional F-actin bundles throughout the comet tail perpendicular to the direction of motion38 in addition to tangentially orientated filaments to the bacterial surface suggest that elastic propulsion is the major driving force of Lm propulsion.
These studies are reminiscent of the debate concerning the lamellipodial actin network in migrating cells. The canonical view of Arp2/3-mediated branched actin networks of lamellipodia28–31 was challenged by a report implicating very little branched actin but instead many overlapping parallel actin bundles40. The suggestion that actin filaments were mainly unbranched in lamellipodia was controversial41–43. Ultimately, a consensus was reached: lamellipodia are once again considered to contain Arp2/3-mediated branches of actin, but there are far fewer of them than expected44. Membrane-tethered actin polymerizers are thought to mechanically and transiently link actin protrusions to the leading edge plasma membrane of a migratory cell37. This transient F-actin polymerization model is similar to the model of actin propulsion of Lm37. Altogether, these recent studies highlight the fruitful collaboration of studies of F-actin polymerization in cell migration and Lm propulsion.
In addition to actin comet tails, Lm also induces actin-based bacterial protrusions at the host cell plasma membrane to drive cell-to-cell spread. The actin network in Lm-mediated protrusions is composed of parallel actin filaments38—more parallel and less branched than would be expected for Arp2/3-driven polymerization. The Rho-family GTPase cell division cycle protein 42 (Cdc42) is a conserved upstream regulator of host nucleation-promoting factors and Arp2/345,46 but has no role in Lm actin comet tail formation47. In polarized epithelial tissue culture, Lm actin-based protrusions must counteract cortical tension. Lm partially relieves this tension by secreting the protein InlC, which inhibits Tuba, a Cdc42 activator48,49. While these results suggest that Cdc42 activity restricts Lm cell-to-cell spread, a subsequent report by another group suggests that membrane protrusion formation requires active Cdc42 and the actin regulator formin50, which induce bundled F-actin. The reason for the conflicting requirements of Cdc42 activity for Lm cell-to-cell spread is unclear, although the authors speculate that the discrepancy may be because of the difference in cell types used (polarized epithelial Caco-2 versus non-polarized HeLa cells). Further work is required to ascertain the different requirements for Cdc42 activity in Lm intercellular spread and how the choice of model tissue culture affects these requirements.
Recently, new host cell factors that are recruited to the Lm comet tail were discovered. In addition to the known ActA targets Arp2/3 and enabled/vasodilator-stimulated phosphoprotein (Ena/VASP)51–54, ActA was recently shown to recruit lamellipodin. Lamellipodin is a binding partner of Ena/VASP and an actin regulator in lamellipodia55 that promotes Lm cell-to-cell spread56. Interestingly, lamellipodin is recruited to Lm actin comet tails independently of Ena/VASP, highlighting that lamellipodin can bind to F-actin. Although lamellipodin promotes cell-to-cell spread, curiously, lamellipodin knockdown increased the speed of actin-propelled Lm56. How lamellipodin both promotes Lm intercellular spread and appears to reduce Lm comet tail speed remains to be clarified. Another group has found that lamellipodin can bind directly to F-actin independently of Ena/VASP in vitro and in cultured migratory cells, possibly promoting lamellipodial formation55. Together, these results highlight the subversion of host cell lamellipodial formation by Lm to induce cell-to-cell spread.
Actomyosin contractility and Lm. Non-muscle myosin II (myosin) is an actin-based motor protein that assembles into bipolar filaments to exert contractile forces. Interestingly, myosin is known to inhibit Lm infection48. As mentioned above, suppression of Cdc42 activity in polarized epithelial cells favors cell-to-cell spread, presumably through relaxation of cortical tension48,49. However, direct quantification of the relaxation of cortical tension by Lm is lacking, and it would be interesting to measure tension as routinely performed in developmental biology research57,58. In addition, pharmacological inhibition of myosin was shown to favor Lm host cell adhesion and invasion59. Phosphorylation of the myosin heavy chain at a conserved tyrosine residue was detected in response to Lm infection60. Although phosphorylation of this tyrosine has been previously predicted in muscle myosin heavy chain61, its impact on myosin contractility is unknown. Myosin activity seems to protect plasma membrane integrity from LLO-induced damage and this leads to increased host survival in vivo in a zebrafish infection model62, although the underlying mechanism remains unclear.
Furthermore, formin and the actomyosin regulator Rho-associated kinase (ROCK) induce the internalization of Lm into endothelial cells63. While in other cell types (such as epithelial and fibroblast) ROCK inhibits the entry of Lm, ROCK appears to favor bacterial adhesion to the cell surface of endothelia63. It will be interesting to see if other regulators of actomyosin cortical tension cell–cell adhesions (for example 64) are involved in Lm infection.
Lm is known to alter the host endoplasmic reticulum (ER). Indeed, Lm induces ER stress and the unfolded protein response65. The coat complex COPII, required for ER-to-Golgi trafficking66, was recently found to restrict Lm cell-to-cell spread in polarized epithelial tissue culture67. In addition, we discovered that Lm infection induces the expression of the small ubiquitin-like modifier interferon-stimulated gene 15 (ISG15) in non-phagocytic cells, triggering an ISGylation of a number of ER and Golgi proteins and increasing cytokine secretion68. Furthermore, studies have uncovered a novel role for Gp96 (glycoprotein of 96kDa), an ER resident protein chaperone. Lm infection was already known to trigger Gp96 recruitment from the ER to the plasma membrane, becoming exposed to the cell surface and co-localizing with surface bacteria69,70. Recently, Gp96 was shown to be recruited to sites of LLO-induced blebbing along with myosin62, but the underlying mechanisms are unclear. It will be interesting to see if there are other strategies used by Lm to perturb trafficking between endomembrane components, especially in the context of different cell types.
Lm pathogenesis relies on the ability of the bacterium to traverse several physiological barriers, including the intestinal epithelium and the placenta, and survive in multiple cell types71.
Passage through the intestinal epithelial barrier is the first port of entry for Lm into the host. Interaction of the Lm surface protein InlA with E-Cadherin (E-cad), the host adherens junction epithelial cadherin is the key step in Lm intestinal invasion. Although E-Cad is localized to the basolateral membrane of vertebrate epithelial cells and would thus be generally inaccessible to Lm in the intestinal lumen, E-Cad is accessible at extruding cells at intestinal villi tips72 and in mucus-secreting goblet cells73. The interaction between InlA and human E-Cad is species specific74. Thus, a knock-in transgenic mouse line bearing a point mutation in E-Cad that allows for the InlA–E-Cad interaction is used for oral infections with Lm75,76, although many studies are still performed with non-transgenic mice21. InlA–E-Cad interaction triggers rapid transcytosis of Lm through goblet cells into the basal lamina propria73. Recent work has shown that phosphoinositide 3-kinase (PI3-K) is constitutively active in the intestine, explaining why the Lm surface protein InlB, which is known to activate PI3-K, is not required for crossing the intestinal barrier77. Interestingly, it was shown that Lm is mostly extracellular in the intestine of orally infected mice and that the intracellular pool is a minor but important fraction during infection78. The majority of Lm in the gut was discovered to be associated with monocytes, but there is very poor intracellular growth79 in these cells.
Lm is one of the few pathogens capable of traversing the placental barrier. It requires both InlA and InlB75,80. InlA-mediated invasion of Lm into the placenta requires InlB-dependent activation of PI3-K77. Furthermore, a new Inl, InlP, has been discovered as an enhancer of placental invasion in both human placental explants and in vivo infection of guinea pigs and mice81, although the mechanisms through which InlP acts remain to be elucidated.
An emerging field of investigation is the interaction between the host gut microbiota and enteropathogens. Pre-colonization with lactobacilli protects mice against oral infection by Lm82. Administration of Lactobacillus affects the expression of host genes and Lm protein-coding genes and small RNAs82. In addition, the host gut microbiota interferes with the host microRNA (miRNA) response upon Lm oral infection83. Recently, we uncovered that epidemic strains of Lm express a bacteriocin in the gut of orally infected mice, altering the host gut microbiota to favor Lm infection21. It will be interesting to investigate whether Lm has other means with which to modulate the host gut microbiota. These results are beginning to uncover the interplay among the host, the host’s microbiota, and the enteropathogen Lm.
The rise of fast genomic sequencing has opened new avenues to study Lm–host interactions. The plethora of genomic data and development of new bioinformatic tools have greatly facilitated the study and comparison of multiple Lm strains and other closely related Listeria species84,85. The development of proteogenomics and the integration of sequencing and mass spectrometry have uncovered novel anti-sense RNAs86 and novel mini-proteins87 of Lm. Unsurprisingly, different Lm strains possess differences at the genomic, transcriptomic, and pathogenic level85,88. For example, the novel Lm bacteriocin cited above that targets the host gut microbiota21 is present in epidemic Lm strains but is absent in the standard reference laboratory strains. Certain epidemic strains appear more virulent in animal studies and are able to infect the central nervous system and traverse the placental barrier in human cases of listeriosis89. In contrast, many of the reference laboratory strains are poorly neuroinvasive90, suggesting that analysis of clinical isolates may be more fruitful for the investigation of human disease.
Recent genomic comparative studies of multiple strains, both laboratory and clinical84,85,90,91, including the recently sequenced 306 draft genomes of Lm isolates92, have highlighted that analysis of Listeria biodiversity and genomic conservation is quite informative for the understanding of virulence. Identification of genomic regions over-represented in more virulent strains as well as differences at the transcriptomic level are promising ways to uncover novel bacterial factors involved in infection and in clinical hypervirulence. The recent development of Listeriomics, an online tool to easily compare sequenced Listeria species, should be very instrumental in this post-genomics approach93.
Recent discoveries have advanced our understanding of Listeria–host interactions. Novel cues for the upregulation of virulence factors as well as the discovery of genes expressed exclusively in vivo highlight the need for consideration of the environment and tissues during Lm infection. In the near future, high-throughput sequencing and bioinformatics of multiple Listeria species will yield more insights into the mechanisms by which Lm subverts the host during infection in vivo.
ActA, actin assembly-inducing protein; Arp2/3, actin-related protein 2/3; ARPC(1–5), Arp complex proteins 1–5; Cdc42, cell division cycle protein 42; E-Cad, epithelial-cadherin; Ena/VASP, enabled/vasodilator-stimulated phosphoprotein; ER, endoplasmic reticulum; Gp96, glycoprotein of 96 kDa; Inl, internalin; ISG15, interferon-stimulated gene 15; LLO, listeriolysin O; Lm, Listeria monocytogenes; PI3-K, phosphoinositide 3-kinase; PrfA, positive regulatory factor A; ROCK, Rho-associated kinase.
Daryl J.V. David is supported by an EMBO Long Term Fellowship (ALTF 140-2014) and the European Commission/Marie Curie Actions (EMBOCOFUND2012, GA-2012-600394).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We wish to thank Dr Olivier Dussurget and Dr Nathalie Rolhion for critical and fruitful discussion of the manuscript. We apologize to colleagues whose work could not be cited due to space limitations.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 1 13 Jul 17 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)